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Abstract
In an earlier study, we showed that cytochrome c oxidase activity, measured in mitochondria isolated from human
 .muscular biopsies, decreased steadily and substantially between the age of four years and adulthood P-0.05 , whereas
complexes I and III activity remained constant. The present study investigates a number of possible causes for this change
in activity: although there is a drop in the apparent V , neither the apparent enzyme K , nor the cellular mtDNAmax m
concentration shows any variations over the studied period. Steady-state concentrations of mitochondrial gene transcripts
 .CO I, CO II, CO III, but also 12S, cytochrome b, or ND4 increase within this age group, indicating an overall increase in
mitochondrial genome expression. Concentrations of transcripts of nuclear genes CO IV, CO Vb, and CO VIaH likewise
 .show an increase, albeit less marked. On the other hand, heme aa3 levels and concentrations of mitochondrial CO II or
 .nuclear CO IV, CO VIIaH subunits, estimated using specific antibodies, correlate closely with enzymatic activity and
show a parallel decrease between 4 and 20 years. The observed decrease in complex IV activity is thus quantitative, and
subject to post-transcriptional andror post-translational regulation.
 .Keywords: Cytochrome c oxidase; Muscle; Mitochondrion; Human
1. Introduction
Cytochrome c oxidase or complex IV ferrocyto-
.chrome-c:oxygen oxidoreductase, EC 1.9.3.1 is the
last enzymatic complex of the mitochondrial respira-
tory chain. It catalyzes the transfer of four cy-
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tochrome c electrons to molecular oxygen, via a
redox reaction.
In mammals, complex IV is made up of 13 differ-
w x ent polypeptides 1,2 . Three subunits CO I, CO II
.and CO III are coded by the mitochondrial genome,
the other ten being of nuclear origin. In man, two
nuclear subunits, VIa and VIIa, present as two iso-
 . w xforms L and H 3–8 . These isoforms show tissue
specificity, and their profiles of expression vary dur-
w xing development 9 , in the course of myogenic dif-
w xferentiation 10 .
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Nuclear subunits are involved in the regulation of
complex IV enzymatic activity. Some of these sub-
units may modulate enzymatic activity via allosteric
 . w xeffectors qualitative regulation 11 . Moreover, cer-
tain nuclear subunits may have a limiting effect on
assembly of the complex, thereby allowing modula-
 .tion of its biosynthesis quantitative regulation
w x12,13 . This long-term regulation, which may occur
at the transcriptional or translational level, enables
enzyme quantities to be adapted as a function of
w xgiven tissular requirements 14 .
w xIn an earlier study 15 , we showed a very substan-
tial decrease in complex IV activity in muscle mito-
chondria of children aged between 4 years and adult-
hood. This decrease occurs gradually, and is neither
muscle- nor sex-dependent. Moreover, the decrease is
strictly limited to complex IV, since enzymatic activi-
ties of citrate synthetase and of complexes I and III
show no variations for this same age group. We thus
sought to determine the possible causes of this varia-
tion in complex IV enzymatic activity during devel-
opment. The research presented hereafter allowed us
to ascertain that the variation in activity is mainly
quantitative, and occurs during biosynthesis of com-
plex IV.
2. Materials and methods
2.1. Origin of the biopsies
Muscular biopsies were taken during orthopedic
surgery in the Pediatric Surgery Department of
Hotel-Dieu, Clermont-Ferrand in keeping with theˆ
Authorization of the Consultative Committee for the
Protection of Persons Undergoing Biomedical Re-
.search, Auvergne region . All fresh muscle speci-
mens were those of a previous study where none of
the studied muscles presented any anomaly in terms
of structure or fibre distribution, and none of the
children from whom specimens were taken presented
disorders imputable to mitochondria. The reasons for
surgery were most often injury or congenital malfor-
mations. Muscular biopsies were taken from six dif-
ferent muscles, and yield milligram of protein from
.the mitochondrial fraction per gram of muscle , and
enzymatic activities of citrate synthase, complexes I,
III and IV, showed no significant difference in terms
of muscle, in terms of sex, or in terms of age except
.for complex IV . Age of the studied controls ranged
 .between 3.5 and 22 years means11.2 , with homo-
w xgeneous distribution of the various ages 15 .
Just after removal, a part of the biopsy about
.50–100 mg was frozen in liquid nitrogen, and stored
at y708C until analyzed. The rest of the fresh tissue
was used immediately, the mitochondrial isolation
and the measurement of enzymatic activities citrate
.synthase and cytochrome c oxidase were performed
w xin keeping with the procedure already described 15 .
2.2. Kinetics studies
The rate of oxidation of horse ferrocytochrome c
 .Sigma was measured at 550 nm with a Beckman
DU8 spectrophotometer in KH PO 30 mM, EDTA2 4
1 mM, pHs7.4. Reduced cytochrome c was added
 .to a final concentration of 5–50 mM. K in mMm
and V in nmolrminPmg of mitochondrial pro-max
.teins values were determined from the straight-line
Lineweaver–Burk plots by computer analysis of the
data.
2.3. Extraction of nucleic acids
 .Total cytoplasmic and mitochondrial DNA and
RNA were prepared from frozen tissues. Muscles
were grounded in a lysis buffer urea 7 M, Tris 10
.mM, EDTA 10 mM, NaCl 0.3 M, pHs8 and
incubated 2 h at 568C. After extraction of proteins
with phenolrchloroform, DNA was recovered by
ethanol precipitation and incubated 30 min with
 .RNase at 378C RNase A . In a parallel manner,
RNA was extracted from muscle with RNA-ZOL
 .Bioprobe System . Proteins were removed by phe-
nolrchloroform extraction and RNA was recovered
by ethanol precipitation. DNA and RNA concentra-
tions in tissues extracts were estimated spectrophoto-
metrically from A260.
2.4. Nucleic acid hybridization procedures
Total DNA was blotted directly to nylon filters
 .slot-blot , and total RNA were transferred by blot-
ting from agarose formaldehyde gels. Nucleic acids
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immobilized on nylon filters were hybridized to sev-
w 32 xeral probes labeled with a- P dCTP by random
priming. Seven probes were obtained by PCR
amplification of total muscle DNA with specific
 .  Xprimers Eurogentec Belgium : 12 S sens 5 -GC-
CTAGCCACACCCCCACGGG-3X; anti-sens 5X-AG-
X.  XGAGGGTGACGGGCGG TGT-3 , CO I sens 5 -
CTACTAACAGACCGCAACCT-3X; anti-sens 5X-
X. ACATAGTGGAAGTGGGCTAC-3 , CO II sens
5X-CAAGTAGGTCTACAAGACGC-3X; anti-sens 5X-
X.CCACAGATTTCAGAGCATTG-3 , ATP6-CO III
 X Xsens 5 -GTTCGCTTCATTCATTGCCC-3 ; anti-sens
X X. 5 -GGATTATCCCGTATCGAAGG-3 , ND 4 sens
5X-TACACTCACAACACCCTAGG-3X; anti-sens 5X-
X.GGTGTATGAACATGAGGGTG-3 , cytochrome b
 X Xsens 5 -CCAATGACCCCAATACGCAA-3 ; anti-
X X.sens 5 -AATGGGAGGTGATTCCTAGG-3 and CO
 X XVIIaH sens 5 -TGATCCGCTCCTTCAGCTCC-3 ;
X X .anti-sens 5 -TTGTTCAAGTCTCTCAGGCCC-3 .
All PCR products were purified Geneclean, BIO
.101 , then used directly for random priming. For the
ATP6-CO III amplification, the PCR product was
first cut with Apa I, and the 190 bp fragment, specific
to CO III, was isolated then purified before random
priming.
The probes for nuclear messengers of complex IV
 .CO IV, CO Vb, CO VIaL, CO VIaH and CO VIIaL
w xare a gift from G. Bonne 9 .
2.5. Immunoblotting
Quantitation of the three subunits CO II, CO IV
.and CO VIIaH in the mitochondrial fraction was
performed by immunoblotting. Equivalent amounts of
isolated mitochondria were incubated at 408C for 2 h
in a denaturing buffer Tris-HCl 50 mM, pHs6.8
containing 12% vrv glycerol, 1% prv SDS, 4% vrv
b-mercaptoethanol and 0.01% prv Bromophenol
.blue and loaded on a 12% polyacrylamide-SDS gel
 .18% for the CO VIIaH subunit . After migration, the
proteins were electroblotted onto nitrocellulose mem-
 .branes 0.1 mm pore size, Schleicher and Schull .
Immunodetection of complex IV subunits was per-
formed by incubation with primary antibodies anti
CO II is a gift from A. Lombes, anti CO IV is obtain
from Molecular Probes and anti COP VIIaH is a gift
.from S. Possekel at a dilution of 1:1000. Blots were
analysed using goat anti-mouse IgG or goat anti-rab-
bit IgG conjugated to alkaline phosphatase at a dilu-
 .tion of 1:5000 Sigma , followed by BCIPrNBT
 .staining Promega .
2.6. Hybridizations and immunoblotting signals anal-
ysis
Autoradiographies and stained membranes were
 .scanned OneScanner, Apple and numeric images
were analysed with a specific software Graphteck,
.France to quantify the intensity of each signal.
2.7. Heme aa3 concentration measurements
From the freshly isolated mitochondria, 100 mg of
proteins are incubated 5 min at room temperature in
 .1% Triton X-100 Sigma . Insoluble materials are
 .removed by a brief centrifugation 5 min, 12 000=g .
 .The heme aa3 concentration in pmolrmg was cal-
culated from difference spectra dithionite-reduced
.minus air oxidized with a Shimadzu UV 160-A
spectrophotometer and using an extinction coefficient
at 605–630 nm of 24 mMy1 cmy1. The heme aa3
concentration was then expressed in citrate synthase
 .units ratio: heme aa3rcitrate synthase activity in
order to obtain the amount of assembled enzyme per
mitochondrial volume.
2.8. Statistical analysis
Statistical analysis were done as already described
w x15 . For comparison of data groups, the correlation
was calculated to obtain the equation for the regres-
sion curves, the value of the correlation coefficient,
and the statistical significance of correlation in keep-
ing with the Fischer and Yates table. Results were
validated as non-significant if P)0.05, significant if
0.01-P-0.05, very significant if 0.001-P-0.01,
and highly significant if P-0.001.
3. Results
In a previous study, we showed that the age-re-
lated decrease in complex IV enzymatic activity is a
phenomenon which occurs gradually during develop-
w xment, between the age of 4 years and adulthood 15 .
We formulated several hypotheses and carried out
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Fig. 1. Evolutions with age of kinetic parameters. Apparent Km
and apparent V were determined as described in Section 2.max
Statistical analysis were done showing a non-significant correla-
 .  .tion P )0.05 for the K A , and a highly significant correla-m
 .  .tion P -0.01 for the V B . Lines represent regressionmax
curves.
several studies to determine the causes of this de-
crease. The variation in activity may be qualitative,
i.e., a change in composition of the complex or of its
environment, giving rise to a variation in enzymatic
activity. The variation in activity may also be quanti-
tative, in which case a decrease in the enzyme quan-
tity per citrate synthetase unit, thus per mitochon-
.drium would account for lowered activity.
3.1. Kinetic approach to complex IV
An analysis of correlation was performed between
the calculated V and K values and age of sub-max m
jects. The clusters of points and regression curves are
shown on Fig. 1. Statistical analysis shows that the
correlation is not significant for apparent K . On them
other hand, the apparent V shows a highly signifi-max
 .cant correlation with age P-0.01 . In adult biop-
sies, characterized by a lower complex IV activity,
the enzyme quantity may be smaller than in biopsies
from young children, characterized by high complex
IV activity. This would account for V variations,max
despite the apparent lack of change in K .m
3.2. Measurement of cytochrome le˝els
Measurements of the quantity of aa3 hemes by
difference spectra were performed on the mitochon-
drial fraction of several biopsies. Because of the
required protein quantities, only 12 biopsies could be
analyzed. Values are expressed as citrate synthetase
units amount of assembled enzyme per mitochon-
.drial volume , and the cluster of points and regression
curve are shown on Fig. 2. As with the kinetic
studies, the correlation between the concentration of
aa3 hemes and age was analyzed, and proved to be
 . statistically significant P-0.05 . Young children 4
.years , who show most enzymatic activity, present
larger quantities of aa3 hemes than young adults 20
.years , in whom enzymatic activity is not as high.
Fig. 2. Evolutions with age of hemes aa3 content. Cytochrome
content measurements were done on isolated mitochondria and
are expressed in citrate synthase units as described in Section 2.
Statistical analysis were done showing a significant correlation
 .P -0.05 and line represents regression curve.
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The observed variations in complex IV activity with
age are thus linked to quantitative variations in the
cytochrome concentration.
3.3. Measurement of mtDNA le˝els
To study possible variations in mitochondrial gene
concentrations, mtDNA levels of several biopsies
were assessed using the ‘Slot-blot’ technique. The
mtDNArnuclear DNA signal ratio allows the quan-
tity of mtDNA per nuclear genome to be assessed.
The mtDNArnuclear DNA ratio obtained for one
 .biopsy from the youngest child was arbitrarily sup-
posed to be equal to 1, and used as a reference for
comparison with all the other biopsies.
A study was conducted to determine the correla-
tion between mtDNArnuclear DNA and subject age.
The cluster of points and regression curve are shown
on Fig. 3. The correlation is not statistically signifi-
 .cant Ps0.48 ; cellular levels of mtDNA can thus
be considered as constant between 4 and 22 years.
3.4. Measurement of expression of se˝eral mitochon-
drial genes and complex IV nuclear genes
Levels of expression of several complex IV mito-
chondrial and nuclear genes as a function of age were
assessed by Northern blot measurements based on
total RNA extracts from 15 biopsies. To correct
individual variations and allow comparison of the
various hybridizations, measurements were per-
formed for three different ages: 5 years, 10 years and
 .18 years 5 extracts for each age group . Hybridiza-
tion signals obtained with the various probes were
compared with the signal obtained using the 18S
 .probe Fig. 4A . Results are expressed as a function
of the value obtained in 5-year-old children.
3.4.1. Mitochondrial gene expression
Evolution of steady-state concentrations of the
three mitochondrial transcripts of complex IV CO I,
.CO II, and CO III as a function of age is shown on
Fig. 4B. The relative steady-state concentration of
these three transcripts shows an increase, with about
2.5 times more RNA at 18 years than at 5 years.
Expression of 12 S, cytochrome b and ND 4 genes
Fig. 3. Evolution with age of mtDNArnuc. DNA ratios. Cellular
 .mtDNA contents were estimated by slot-blot A from total DNA
after RNase treatment. Correlation between mtDNArnuc. DNA
 .and age was statistically studied B , showing a non-significant
 .correlation P s0.48 . Line represents regression curve.
as a function of age is shown on Fig. 4C. Just as with
RNA from complexes IV, these levels show an in-
crease, which is more marked for transcripts of com-
 .  .plex I ND 4 and III cytochrome b than for the
 .ribosomal transcript 12S . The steady-state RNA
concentration is about 3 times higher at 18 years than
at 5 years, and is increased by 1.6 for 12 S.
Results thus confirm an overall increase in mito-
chondrial genome expression with age, whereas
mtDNA levels remain constant. Nevertheless, we
cannot speculate whether this increased expression is
due to an increase in transcription or in messenger
stability.
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3.4.2. Expression of complex IV nuclear genes
Concentrations of nuclear transcripts of subunits
CO IV, CO Vb, and CO VIaH were studied as a
function of age. Results are presented on Fig. 4D.
There is no important variation in transcript con-
centrations, despite a slight increase in CO IV and
CO Vb messenger levels. There is no clear evolution
in CO VIaH, although this result may be imputable to
quantification difficulties for this particular transcript.
The variation is thus less marked for these transcripts
than for mitochondrial RNA.
We studied expression of the L and H isoforms of
nuclear subunits CO VIa and CO VIIa. For RNA of
these subunits, we sought the presence of L isoforms
in muscle extracts of children of different ages. Un-
der our study conditions, given the limited availabil-
Fig. 4. Relative expression of several mRNA during development. Steady-state levels of ten RNAs were studied by Northern blot at three
 .  . different ages 5, 10 and 18 years . Left panel A , shows one of five independent experiments lane 1: 5-year-old child, lane 2:
.10-year-old child, lane 3: 18-year-old child, 10 mg of total RNA were used in each case . Hybridization signals obtained for the nine
 .mRNAs were first divided by the signal obtained for the rRNA 18S , then expressed relatively to the ratio obtained in lane 1. Means
 .  .were done within the five experiments and results are plotted in the right panel for the 6 mt RNAs B and C and the 3 nuclear RNAs D .
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 .ity of RNA quantities 10 mg per lane , these iso-
forms are undetectable, while H isoforms are present.
There is thus apparently no important change in
steady-state concentrations of VIaL and VIIaL RNA
Fig. 5. Evolutions with age of complex IV subunits amounts.
 .Relative amounts of complex IV subunit CO II A , subunit CO
 .  .IV B and subunit CO VIIaH C were estimated by Western
blot using specific antibodies. In each case, one sample is chosen
as reference, and others are expressed in relation to this refer-
ence. Statistical analysis were done showing a significant correla-
 .tion in each case P -0.05 and lines represent regression curves.
between 4 and 18 years, i.e., during the period for
which we showed a decrease in complex IV activity.
The disappearance of L isoforms in the muscle would
thus seem to occur very early, before or during the
neonatal period, or at the latest by the age of 4 years.
3.5. Quantitati˝e measurement of se˝eral complex IV
protein subunits
A Western blot study of protein subunits CO II,
CO IV and CO VIIaH of cytochrome c oxidase was
carried out using specific antibodies. For these 3
subunits, a study was carried out to determine the
correlation between relative staining intensity and age
of subjects. The three correlation graphs and corre-
sponding regression curves are shown on Fig. 5.
The correlation is statistically significant in the 3
cases, with P-0.01 for subunit CO II and P-0.05
for nuclear subunits CO IV and CO VIIaH. As with
 .cytochrome levels, youngest children 4 years , char-
acterized by the highest enzymatic activity, show the
largest quantities of protein subunits. This result con-
firms the hypothesis of a quantitative decrease in
complex IV between 4 years and adulthood.
Although the correlation between age and subunit
quantities is more marked with the mitochondrial
 .subunit CO II than with the two other subunits of
nuclear origin, this difference is probably due to
experimental conditions. Indeed, low molecular
weights of the latter two subunits make them difficult
to detect. Moreover, primary antibodies used for CO
II are polyclonal, whereas those used for CO IV and
CO VIIaH are monoclonal, reducing detection effi-
cacy.
4. Discussion
The age-related decrease in complex IV activity
w xhas already been reported by several authors 16–23 .
It has chiefly been described during senescence, and
studies in the literature have rarely dealt with subjects
younger than 20 years. In an earlier study, we showed
a significant decrease in complex IV activity during
human muscle development between the age of 4
years and adulthood. Research presented here al-
lowed us to study several characteristics of complex
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IV and of its biosynthesis, in order to determine the
causes of this decrease.
4.1. Qualitati˝e ˝ariation
The age-related decrease in enzymatic activity may
reflect a variation in composition of the complex in
terms of its subunits, which may lead to differences
in catalytic performance. The three mitochondrial
 .subunits responsible for catalytic activity are coded
by the mitochondrial genome and present no iso-
forms. An intrinsic variation in complex IV should
thus involve subunits of nuclear origin, and be depen-
dent on age or stage of development. Recent research
has shown such variations to exist in man, between
the embryonic and adult stage, for two nuclear sub-
units, VIa and VIIa, which possess specific develop-
w xment isoforms 9,24 . Moreover, complex IV presents
different kinetic parameters according to its L and H
w xisoform composition 25 .
Our study of transcripts isolated from biopsies
shows that, as in adult muscle, there are practically
no L isoform transcripts of VIa and VIIa genes, only
H isoform transcripts being detectable. The adult
form of muscular complex IV is already present at 4
years. The transition between L and H isoforms is
therefore not responsible for the variation in activity
observed after 4 years. Schillace and his collaborators
w x26 showed that transition occurs during the last fetal
stages in bovines.
The variation in activity may also reflect modifica-
 .tions to kinetic parameters V or K of themax m
complex, brought about by effectors which are extrin-
sic to the complex itself. Such effectors intramito-
.chondrial or cytosolic may act on subunits of mito-
 .chondrial origin catalytic or of nuclear origin, such
w x w x w xas ADP 27 , ATP 28 , or diiodotyronines 29 . The
lipid environment of complex IV, notably membrane
levels of cardiolipids, which may influence its enzy-
w xmatic activity 30–32 , could also be involved. Our
kinetic parameter determinations indicate that the
apparent K of complex IV remains constant be-m
tween 4 and 20 years.
Although modulation of intrinsic activity by effec-
 .tors cytosolic andror mitochondrial cannot be ruled
out altogether, decreased activity within this age group
would not seem to be attributable to a major qualita-
tive change in the actual complex.
4.2. Quantitati˝e ˝ariation
Our results indicate that the decrease in enzymatic
activity observed during development correlates with
a decrease in the enzyme quantity, between 4 and 20
years. This is apparently not due to a reduction in the
intramuscular mitochondrial population, since the ex-
traction yield for isolated mitochondria showed no
decrease; on the contrary, mitochondrial quantities
w xper gram of muscle remained constant 15 . More-
 .over, citrate synthetase activity per mg of protein
did not vary in the mitochondrial fraction isolated
from children of different ages. Hence, the decrease
in complex IV enzymatic activity indeed appears to
result from a decrease in the intramitochondrial en-
zyme quantity.
This hypothesis is borne out by several results.
Measurements of aa3 heme levels, and quantitative
measurements of concentrations of several protein
 .subunits mitochondrial and nuclear using specific
antibodies show enzymatic activity to be directly
related to the quantity of enzyme. The youngest
children, who have the highest complex IV enzymatic
activity, likewise show greater quantities of cy-
tochromes and protein subunits than older control
subjects, in whom enzymatic activity is lowest. The
variation in activity between 4 and 20 years is there-
fore at least partially due to a quantitative decrease in
the complex. This decrease in the intramitochondrial
quantity of functional complex IV may be at-
tributable to several factors, notably to regulation at
one of the complex biosynthesis levels:
Analysis of mtDNA content shows that the varia-
tion in enzymatic activity is not attributable to a
decrease in the quantity of information necessary for
synthesis of the catalytic subunits. Van den Bogert et
w xal. 33 tested various tissues and cell lines, and
showed that there was no direct relation between
mtDNA quantities and complex IV activity.
Our results obtained by studying various tran-
scripts indicate an increase in the mitochondrial
genome level of expression. This increase is shown
not only for complex IV genes, but also for some
genes of complexes I and III, which are not con-
w xcerned by a decrease in enzymatic activities 15 . For
these genes encoding complexes subunits, mRNA
steady-state levels are about three times higher at 18
years than at 5 years, whereas the increase is only 1.6
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fold for the rRNA 12S. For this ribosomal messenger,
the steady-state level is 30 to 40 times higher than
w xmRNA 34 , which could explain the lower increase.
Expression of the studied complex IV nuclear
genes likewise shows an increase, although it is less
marked than for mitochondrial transcripts. For these
two transcript populations, increased transcription or
messenger stability, or a combination of both factors,
may be involved. These results comply with several
studies showing coordinated expression of the two
w xgenomes 9,33,35 . Furthermore, several authors have
reported an increased level of transcription of all
complex IV genes, between the human fetus and
w xadult 9 , and during development between birth and
w xadulthood in the mouse 36 .
The decrease in the quantity of complex IV there-
fore does not result from lowered expression of genes
of this complex. Nevertheless, one or several nuclear
messengers among those we have not studied may be
present in limiting quantities, thereby regulating the
quantity of synthesized complex IV.
There is no direct relation between steady-state
transcript and protein levels. Identical results have
w xalready been published by various authors 37,38 .
One or several mechanisms ensuring post-transcrip-
tional or post-translational regulation must therefore
be envisioned to account for the discrepancy between
w xthese two parameters 35 .
The discrepancy may be attributable to a decrease
in translation of mitochondrial mRNA of the com-
plex, in which case the quantity of available, synthe-
sized, catalytic subunits would constitute a limiting
factor for functional complex IV assembly. In yeast,
specific nuclear factors are involved in control of
translation of several mitochondrial mRNA, notably
w xCO III and cytochrome b 39,40 . No factor of this
type is currently known in mammals. Several authors
have nevertheless postulated the role of such factors,
apparently operative at the level of interactions be-
w xtween mRNA and mitoribosomes 41,42 , or at the
w xlevel of protein synthesis initiation 43 ; these factors
might control the translation level of each of the
mitochondrial messengers.
This phenomenon may alternatively be attributable
to lowered nuclear mRNA translation whereas
.steady-state concentrations show an increase , thus to
a decrease in the quantity of nuclear subunits avail-
able in the mitochondria. Such a modulation in trans-
lation of these mRNA was proposed by Luis et al.
w x38 : these authors observed a possible accumulation
of non-translated nuclear transcripts in the rat, during
the antenatal period. On the other hand, they ob-
served a sharp increase in b 1ATPase protein synthe-
sis in neonates, despite a stable transcript level. ‘Rel-
ative translational efficacy’ may thus vary as a func-
tion of development stage.
The discrepancy may also be due to a decrease in
nuclear subunit imports into the mitochondria. Never-
theless, such a limiting stage would have to specifi-
cally affect subunits of this particular complex there
is no significant drop in complex I and III activity,
w x.15 . Despite relatively comprehensive knowledge of
 w x .protein import systems see 44 for review , import
specificity of this type has yet to be demonstrated.
Finally, the discrepancy may be attributable to
lowered complex IV assembly capacity. Our method
for estimating the quantity of complex IV subunits
does not discriminate between those assembled within
a functional complex and those present in the matrix
or internal membrane. Although the role of chaperone
proteins in the assembly process has been well eluci-
 w x .dated see 45 for review , the possibility of there
being such specific regulation within the assembly
has yet to be described.
Post-transcriptional or post-translational regulation
probably plays an important role in the observed
variation in cytochrome oxidase activity. This de-
crease in activity in the studied age group neverthe-
less raises the issue of correlative physiological mani-
festations: why is potential cytochrome oxidase activ-
ity in young subjects much higher than in older
subjects. Is cytochrome oxidase activity involved in
other processes in very young subjects e.g., in heat
.regulation ? Does the decrease which has already
been described after adulthood, namely during senes-
cence, in fact occur earlier in development?
Better knowledge of factors possibly involved in
coordinating and regulating the expression of nuclear
and mitochondrial genes implicated in mitochondrial
biogenesis should provide answers to these questions.
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